Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 43 of 5804
-
New pill combo takes on hard-to-treat lung cancer in major trial
Disease control Recruiting nowThis is a multicenter, randomized, open-label, phase III clinical study, to evaluate the efficacy and safety of IN10018 in combination with D-1553 as compared to anti-PD-1 monoclonal antibody (mAb) in combination with platinum and pemetrexed as the first-line treatment for the lo…
Phase: PHASE3 • Sponsor: InxMed (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Engineered immune cells take on deadly brain tumors
Disease control Recruiting nowThe purpose of this study is to assess the feasibility, safety and efficacy of Delta-like ligand 3 (DLL3)-specific CAR-T cell therapy in patients with DLL3 positive brain tumors including glioblastomas and diffused intrinsic pontine or midline gliomas (DIPG or DMG). Another goal …
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 26, 2026 17:50 UTC
-
Gene fix trial aims to tame rare immune disease
Disease control ENROLLING_BY_INVITATIONBackground: X-Linked Chronic Granulomatous Disease (X-CGD) is caused by a gene mutation that makes the immune system to not work properly. Researchers want to see if a lentiviral gene transfer treatment will have the ability to make the patient s immune system more normal, in pa…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Double shock may save more cardiac arrest victims
Disease control Recruiting nowSome of the patients affected by Out-of-hospital cardiac arrest (OHCA) with ventricular fibrillation (VF)/ventricular tachycardia (VT) do not respond to initial defibrillation. The survival decreases with number of defibrillations required to terminate VF/VT. In 2022, one prospec…
Phase: PHASE2, PHASE3 • Sponsor: Gabriel Riva • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for pancreatic cancer: targeted drug combo enters final trial phase
Disease control Recruiting nowThe goal of this study is to evaluate the efficacy of QLS31905 in combination with chemotherapy (nab-paclitaxel plus gemcitabine \[AG\]) versus placebo in combination with chemotherapy (AG) in the treatment of CLDN18.2-positive advanced pancreatic cancer in adult participants.
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for aggressive breast cancer: experimental drug ESG401 enters final testing phase
Disease control Recruiting nowThe aim of this study is to evaluate the efficacy and safety of ESG401 as first-line treatment in patients with unresectable recurrent or metastatic triple-negative breast cancer.
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New pill aims to cut heart attacks in people with 'Hidden' cholesterol risk
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy of muvalaplin in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Triple PET imaging could sharpen epilepsy surgery targeting
Diagnosis Recruiting nowThis study focuses on the application value of 18F-FDG, SV2A, and TSPO PET imaging in the preoperative localization of epileptogenic foci in epilepsy. 18F-FDG PET detects glucose metabolism in brain tissue and is characterized by reduced metabolism during the interictal period. I…
Sponsor: Weibing Miao, PhD • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
Balloon in the womb: new hope for babies with rare birth defect?
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety and efficacy of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in cases of severe Congenital Diaphragmatic Hernia (CDH).
Phase: PHASE3 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 26, 2026 13:11 UTC
-
Can safety planning and therapy stop teen suicide? major trial in mozambique aims to find out.
Prevention Recruiting nowThis implementation research project aims to test the effectiveness and implementation outcomes of suicide safety planning along and a transdiagnostic cognitive behavioral intervention for suicide prevention on decreasing suicidal behaviors in secondary school students in Mozambi…
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
New pill aims to control hepatitis b and boost immune response
Disease control Recruiting nowThrough regular monitoring of viral load, liver function and immune cell activity, the long-term efficacy of Adefovir in controlling HBV is precisely evaluated. By employing a dual mechanism of "antiviral action plus immune activation", it offers a novel therapeutic option for ac…
Phase: PHASE3 • Sponsor: Zhigang Ren • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can smartphone volunteers beat ambulances to save overdose victims?
Disease control Recruiting nowOpioids are responsible for the greatest drug-related global health burden. Prevention and treatment programs for people with opioid use disorder are widely implemented, but further actions are required to reduce the mortality and morbidity caused by opioid use and dependence. We…
Phase: NA • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can CAR-T cells beat HIV? tiny trial aims for functional cure
Disease control Recruiting nowAutologous CAR-T cell therapy in HIV-1/AIDS patients
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New laser blood test could spot pancreatic cancer early
Diagnosis Recruiting nowLASERBLOOD is based on a biophotonic technology that can be used to predict the development of Pancreatic Ductal Adenocarcinoma (PDAC) in particular categories of subjects at risk (e.g. persons with diabetes, obese people, patients with Intraductal Papillary Mucinous Neoplasm \[I…
Phase: NA • Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Experimental gene therapy aims to halt fatal brain disease in children
Disease control Recruiting nowThis is a Phase I/II clinical trial of gene therapy for treating X-linked adrenoleukodystrophy using a high-safety, high-efficiency, self-inactivating lentiviral vector (LV) TYF-ABCD1 to functionally correct the defective gene. The objectives are to evaluate the safety and effica…
Phase: NA • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 26, 2026 14:43 UTC
-
Massive study reveals Semaglutide's Heart-Protective power in obesity
Disease control CompletedThis study aims to evaluate the association of once-weekly semaglutide with the risk of cardiovascular (CV) and other obesity-related clinical outcomes in three study populations (Heart failure (HF), clinical Atherosclerotic Cardiovascular Disease (ASCVD), primary prevention). T…
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New RNA drug aims to stop debilitating swelling attacks in rare genetic condition
Disease control Recruiting nowThis study will evaluate the efficacy and safety of ADX-324 in participants with Type 1 or Type 2 hereditary angioedema. The study will also evaluate safety, pharmacokinetics (PK), pharmacodynamics (PD), and health-related quality of life measures.
Phase: PHASE3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a cancer drug stop nerve tumors before they cause harm?
Prevention Recruiting nowPlexiform neurofibromas (PN) are known to cause significant morbidity in children with NF1. The recent FDA approval for selumetinib in children 2 years and older with inoperable symptomatic PN was based on the finding that selumetinib shrinks the majority of PN in children with N…
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
New scan could boost cure rates for rare thyroid cancer
⭐️ CURE ⭐️ Recruiting nowThis is a multicenter, randomized, open-label, non-inferiority Phase III clinical trial, aims to compare 68Ga-CTR-FAPI PET-CT-guided surgery to investigator-chosen surgical approaches to evaluate its efficacy in treating newly diagnosed medullary thyroid carcinoma. This study pla…
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 09:01 UTC
-
New vaccine could shield babies from deadly infection before birth
⭐️ VACCINE ⭐️ Recruiting nowBEATRIX (group B strEptococcus mATeRnal and Infant VaX study) The purpose of this study is to learn about the safety and how the group B streptococcus (GBS) vaccine works in pregnant women and their babies. This study is seeking healthy pregnant participants: * aged 49 or young…
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 11, 2026 00:00 UTC